MHRA Offers Medtechs Extra Transition Time For UK Regulatory System Compliance
UK regulator to allow three- and five-year transitions for CE-marked devices and diagnostics
Executive Summary
26 June saw the release finally of the UK government’s official response to the MHRA’s 2021 consultation on its post-Brexit medical devices regulatory framework. The considered response, held up by political and internal timing issues, represents an implementation plan for reform of the system. Crucially it allows industry extra compliance time.
You may also be interested in...
Unfair Bias In Device Design: UK MHRA And Government Promise Action
A 15-month UK independent review of ethnic and other biases in device design has called for treatment inequity to be addressed at the highest levels of government, more resources for the MHRA and equity assessments to be included in approvals and post market surveillance.
UK Ethnic Bias In Medtech Review To Probe AI Algorithms And Regulatory Gaps
There is potential for ethnic and socio-economic bias in medical device design, funding allocation and regulatory guidelines, according to the UK’s Department of Health and Social Care (DHSC), which has commissioned a review to uncover the extent of the problem.
Vibrant IVDs Innovation Climate At Risk From Poor UK Regulatory System Readiness
The spotlight is on IVDs in the post-COVID phase. Innovators in university spin-outs and the established industry have responded with new technologies, creating a vibrant scene. Regulators and reimbursors must not disrupt the momentum, say BIVDA’s regulatory affairs manager Ashleigh Batchen and chief executive Doris-Ann Williams.